Keywords
Adverse effects
Aged
Polypharmacy, poisoning, psychotropic drugs.
How to Cite
Abstract
Due to chronic noncommunicable diseases (NCDs), polypharmacy in the elderly, which is characterized by the use of multiple medications, is very common and can lead to adverse effects and drug interactions. Primary health care is essential to mitigate these risks, review treatments, prevent problems and improve the quality of life of older adults. This article aims to discuss the importance of primary care in relation to mitigating the adverse effects of polypharmacy in the elderly. The study was carried out through a search in the Medline/PubMed, Virtual Health Library (VHL) and Cochrane Library databases. The research question and strategy used were based on the PICO model. Clinical trials, meta-analyses, randomized controlled trials, full articles, books and documents published in English, Spanish and Portuguese in the last 5 years were included. A total of 251 articles were initially found. After analysis and elimination of duplicates, 134 references were analyzed by title and abstract, of which 76 were included for full reading. After this stage, 64 references were excluded. In the end, 12 studies were considered eligible. Available evidence shows that polypharmacy in the elderly is a growing challenge that requires careful attention, especially in primary health care. Continuous monitoring and regular review of medications are essential to minimize the risks of adverse effects and drug interactions, ensuring healthier aging and a better quality of life for the elderly.
References
ANDRADE, N. DE O. et al. Polimedicação em adultos e idosos cadastrados na Estratégia Saúde da Família. Revista Brasileira de Medicina de Família e Comunidade, v. 15, n. 42, p. 2462, 9 out. 2020.
BLUM, M. R. et al. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial. BMJ, p. n1585, 13 jul. 2021.
DEL CURA-GONZÁLEZ, I. et al. How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention. Journal of Personalized Medicine, v. 12, n. 5, p. 752, 6 maio de 2022.
DOWNING, J. et al. Socioeconomic and health factors related to polypharmacy and medication management: analysis of a Household Health Survey in North West Coast England. BMJ Open, v. 12, n. 5, p. e054584, maio de 2022.
ELEN, E. et al. Polifarmácia em idosos: consequências de polimorbidades polypharmacy in the elderly: consequences of polymorbities. Brazilian Journal of Surgery and Clinical Research -BJSCR BJSCR, v. 35, n. 2, p. 2317–4404, 2021.
ISMP. Desprescrição – reduzindo a polifarmácia e prevenindo erros de medicação. Disponível em: https://www.ismp-brasil.org/site/noticia/desprescricao-reduzindo-a-polifarmacia-e-prevenindo-erros-de-medicacao/.
KOULADJIAN O’DONNELL, L. et al. Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults. BMC Geriatrics, v. 20, n. 1, 12 fev. 2020.
MENEZES, T. S. et al. (2020). Polifarmácia em idosos: um desafio para o cuidado integral à saúde. Revista de Saúde Pública, 54, 85.
MOLIST-BRUNET, N. et al. Improving individualized prescription in patients with multimorbidity through medication review. BMC Geriatrics, v. 22, n. 1, 12 maio 2022.
MCCARTHY, C. et al. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial. PLOS Medicine, v. 19, n. 1, p. e1003862, 5 jan. 2022.
PANTOJA-MOLINA, A. D. et al. Prescripción inapropiada en adultos mayores: Una mirada desde la atención primaria. Revista Clínica de Medicina de Familia, v. 13, n. 2, p. 171–172, 2020.
PIETRASZEK, A. et al. Sociodemographic and Health-Related Factors Influencing Drug Intake among the Elderly Population. International Journal of Environmental Research and Public Health, v. 19, n. 14, p. 8766, 19 jul. 2022.
SAIBA MAIS SOBRE A APS. Disponível em: https://www.gov.br/saude/pt-br/composicao/saps/saiba-mais-sobre-a-aps. Acesso em: 10 dez. 2024
SALARI, P. et al. Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study. PLOS ONE, v. 17, n. 4, p. e0265507, 11 abr. 2022.
WALLIS, K. A. et al. Safer prescribing and care for the elderly (SPACE): cluster randomised controlled trial in general practice. BJGP Open, p. BJGPO.2021.0129, 13 out. 2021.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Lara Pereira do Carmo, Ylanna Ferreira Machado, Maria Wanessa Berto da Silva, Raquel Pinato Costa Machado